SOC Telemed (SOC Telemed) ROCE % : -25.64% (As of Dec. 2021)

View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SOC Telemed's annualized ROCE % for the quarter that ended in Dec. 2021 was -25.64%.

SOC Telemed ROCE % Historical Data

The historical data trend for SOC Telemed's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed ROCE % Chart

SOC Telemed Annual Data

Trend

Dec19

Dec20

Dec21

ROCE %

-19.86

-69.02

-25.64

SOC Telemed Semi-Annual Data
	Dec19	Dec20	Dec21
ROCE %	-19.86	-69.02	-25.64

SOC Telemed ROCE % Calculation

SOC Telemed's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	-41.665	/	( ( (84.939 - 15.94)	+	(274.225 - 18.178) )	/ 2 )
	=	-41.665	/	( (68.999	+	256.047)	/ 2 )
	=	-41.665	/	162.523
	=	-25.64 %

SOC Telemed's ROCE % of for the quarter that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2021 )		(Q: Dec. 2020 )		(Q: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2021 )		(Q: Dec. 2020 )		(Q: Dec. 2021 )
	=	-41.665	/	( ( (84.939 - 15.94)	+	(274.225 - 18.178) )	/ 2 )
	=	-41.665	/	( ( 68.999	+	256.047 )	/ 2 )
	=	-41.665	/	162.523
	=	-25.64 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2021) EBIT data.

SOC Telemed (NAS:TLMDW) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SOC Telemed ROCE % Related Terms

Thank you for viewing the detailed overview of SOC Telemed's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SOC Telemed (SOC Telemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMDW) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190

Website

https://www.soctelemed.com

SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.

Executives

David R. Fletcher	officer: Interim CFO	C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula	officer: Chief Operating Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb	officer: Chief Financial Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p.	director, 10 percent owner	450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge	director	C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co.	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol	director	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee	officer: Chief Technology Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
John W. Kalix	director, officer: Chief Executive Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190